Tag: glucagon

Browse all articles tagged with “glucagon”.

3 articles

Retatrutide: The Triple Agonist Setting New Records in Obesity Research

A research-focused overview of retatrutide (LY3437943), the investigational triple GIP/GLP-1/glucagon receptor agonist from Eli Lilly that achieved 23.7% body weight reduction in Phase 2 trials, the largest ever recorded in an obesity trial.

2026-03-06·15 min read

Retatrutidetriple agonistGIPGLP-1glucagonobesitymetabolic healthEli Lilly

Metabolic Health

Survodutide: The Dual Glucagon/GLP-1 Agonist Targeting Liver Disease

A research overview of survodutide, the investigational dual glucagon/GLP-1 receptor agonist from Boehringer Ingelheim being developed for obesity and NASH/MASH, with a focus on its hepatic fat reduction potential.

2026-01-25·10 min read

SurvodutideglucagonGLP-1dual agonistNASHMASHliver diseaseBoehringer Ingelheimmetabolic health

Metabolic Health

Mazdutide: The Dual GLP-1/Glucagon Agonist From Innovent Biologics

A research overview of mazdutide (IBI362), the dual GLP-1/glucagon receptor agonist developed by Innovent Biologics for the Chinese and global markets, with Phase 3 data showing significant weight loss and metabolic improvements.

2026-01-20·9 min read

MazdutideGLP-1glucagondual agonistInnovent Biologicsobesitymetabolic healthChina

←Back to blog

For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.